ストックスクリーナーアプリを入手
40.16
1.03%
0.41
Vera Therapeutics Inc (VERA) 最新ニュース
Equity grants to Vera Therapeutics (VERA) Chief Legal Officer detailed in Form 4 - Stock Titan
Chief Legal Officer reports initial insider status at Vera Therapeutics (VERA) - Stock Titan
Calif. Biotech Firm Vera Taps Vaxcyte Ex-GC As New CLO - Law360
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer By Investing.com - Investing.com Canada
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer - Quiver Quantitative
Biotech nearing drug launch hires veteran lawyer as legal chief - Stock Titan
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock advances on promising Phase 3 data for atacicept in IgA nephropathy, boostin - AD HOC NEWS
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
(VERA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Investment Firm Boosts Vera Therapeutics Holding to $41.75M in 2026News and Statistics - IndexBox
This $91 Million Investment Reflects Strong Confidence in a Biotech Firm Awaiting an FDA Ruling This Year - Bitget
Hudson Bay Capital Management Boosts Stake in Vera Therapeutics - National Today
Hudson Bay Capital Management LP Raises Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Is Suddenly Taking Off - TipRanks
Volume Summary: What is the next catalyst for Vera Therapeutics Inc2026 Top Decliners & Weekly Setup with High ROI Potential - baoquankhu1.vn
Deep Track Capital, LP Increases Stake in Vera Therapeutics Inc - GuruFocus
Algert Global LLC Acquires 39,235 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) finance chief exercises options for 10,000 shares - Stock Titan
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment - AOL.com
Eversept Partners Increases Stake in Vera Therapeutics - Intellectia AI
Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears - simplywall.st
HighVista Strategies LLC Increases Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics, Inc. $VERA Shares Sold by First Light Asset Management LLC - MarketBeat
Cinctive Capital Management LP Sells 65,510 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Braidwell LP Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Wall Street analysts see a 53.05% upside in Vera Therapeutics (VERA): Can the stock really move this high? - MSN
Integral Health Asset Management LLC Has $49.40 Million Stock Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Avoro Capital Advisors Reduces Stake in Vera Therapeutics - National Today
Avoro Capital Advisors LLC Sells 90,000 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - AOL.com
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - The Motley Fool
Vera Therapeutics, Inc. $VERA Holdings Raised by Schroder Investment Management Group - MarketBeat
Published on: 2026-03-13 13:04:33 - baoquankhu1.vn
Aug Big Picture: What is the cash position of Vera Therapeutics Inc2026 Price Action Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Vera Therapeutics urges expanded innovation in global kidney health on World Kidney Day - Traders Union
Wolfe Research upgrades Vera Therapeutics (VERA) - MSN
Quarterly Trades: Can Vera Therapeutics Inc deliver consistent EPS growth2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Deep Track files 13G disclosing 5.50% stake in Vera Therapeutics (NASDAQ: VERA) - Stock Titan
Vera Therapeutics (NASDAQ:VERA) Upgraded to Outperform at Wolfe Research - MarketBeat
How (VERA) Movements Inform Risk Allocation Models - Stock Traders Daily
Wolfe Research upgrades Vera Therapeutics stock rating on valuation By Investing.com - Investing.com Canada
Vera Therapeutics (NASDAQ:VERA) Trading Up 10.2%What's Next? - MarketBeat
Vera Therapeutics’ Atacicept Gains FDA Priority, Stock Soars - StocksToTrade
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities - Investing.com Canada
Vera Therapeutics Adds Christopher Hite to Board - TipRanks
Vera Therapeutics appoints Christopher Hite to Board as Class III Director - TradingView
Director at Vera Therapeutics (VERA) receives grant of 24,937 stock options - Stock Titan
Director Christopher Hite files initial Form 3 at Vera Therapeutics (VERA) - Stock Titan
Vera Therapeutics Appoints New Board Member - Intellectia AI
Rhenman & Partners Asset Management AB Invests $3.78 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Can Vera Therapeutics Inc. stock deliver surprise earnings beat2026 EndofYear Setup & Weekly Return Optimization Plans - Naître et grandir
GW&K Investment Management LLC Reduces Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
Six new Vera Therapeutics hires receive 4-year stock awards - Stock Titan
Vanguard Group Inc. Has $92.72 Million Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics Appoints Christopher Hite to Board of Directors - Sahm
Vera Therapeutics adds Christopher Hite to board of directors By Investing.com - Investing.com Canada
Vera Therapeutics adds Christopher Hite to board of directors - Investing.com
1.82%
大文字化:
|
ボリューム (24 時間):